Elaine J. Heron - 27 Feb 2026 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Director
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
27 Feb 2026
Net transactions value
+$300,000
Form type
4
Filing time
02 Mar 2026, 08:00:10 UTC
Previous filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HERON ELAINE J Director C/O PALVELLA THERAPEUTICS, INC., 353 W. LANCASTER AVENUE, SUITE 200, WAYNE /s/ Kathleen A. McGowan, Attorney-in-Fact 02 Mar 2026 0001235471

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PVLA Common Stock Purchase $300,000 +2,400 +5.3% $125.00 47,812 27 Feb 2026 Direct F1
holding PVLA Common Stock 5,879 27 Feb 2026 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.